| Original language | English (US) |
|---|---|
| Pages (from-to) | 1615-1627.e1 |
| Journal | Gastroenterology |
| Volume | 161 |
| Issue number | 5 |
| DOIs | |
| State | Published - Nov 2021 |
Bibliographical note
Funding Information:Members of the Guideline Panel and TR Panel were selected by the AGA Governing Board and Chair of the Clinical Guidelines Committee with careful consideration of conflict of interest. The Guideline Panel included gastroenterologists and hepatologists, Grading of Recommendations Assessment, Development and Evaluation methodologists, and a hematologist. Development of this guideline and the accompanying TR was fully funded by the AGA Institute without additional outside funding. The TR and guideline underwent independent peer review and a 30-day open public comment period. A patient was also asked to review this guideline and provide feedback. Panel members disclosed all potential conflicts of interest according to the AGA Institute policy. These disclosure statements are maintained at the AGA Institute headquarters in Bethesda, Maryland. No Guideline Panel member was excused from participation in the process owing to disqualifying conflict.
PubMed: MeSH publication types
- Journal Article
- Meta-Analysis
- Practice Guideline
- Systematic Review